Launched Thiotepa For Injection in 2019 by the brand name Tepawel 15 mg strength.
Approved indications of Tepawel
- Used in conjunction with high-dose busulfin and cyclophosphamide as a preparative regimens for allogeneic hematopoietic progenitor (Stem) cell transplantation (HSCT) for paediatric patients with class 3 beta –thalassemia
- Treatment of adenocarcinoma of the breast or ovary.
- Treatment of superficial papillary carcinoma of the urinary bladder.